Organon Announces Agreement to Divest its JADA System for up to USD 465 Million to Laborie
Organon has entered into a definitive agreement to divest its JADA System to Laborie for up to USD 465 million. The deal aims to leverage Laborie’s expertise in medical technology to expand the reach of JADA, enhancing access to postpartum hemorrhage treatment for mothers worldwide.
Laborie Medical Technologies Corp | 11/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy